All Q4 FY25 results →
DS

DMCC Speciality Chemicals Ltd

Q4 FY25Chemicals & Petrochemicals

DMCC Speciality Chemicals Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹284
Market cap₹710 Cr
P/E26.0
Updated23 Aug 2026
Read4 min read

The short version

The chemical industry generally grows faster than India's GDP, indicating potential for above-GDP growth in sales and volumes. The company does not provide specific future earnings or profit projections, preferring not to make forward-looking statements.

From DMCC Speciality Chemicals Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The chemical industry generally grows faster than India's GDP, indicating potential for above-GDP growth in sales and volumes.
  • Specialty chemicals segment shows strong growth potential with current capacity utilization around 50%, leaving room to nearly double specialty sales from ~INR 210 crores to potentially ~INR 400 crores without major CAPEX.
  • New product launches in specialty areas like sulfur and boron chemicals are expected to gain traction over the next 2-3 years, contributing to revenue growth.
  • Bulk chemical volumes are near full capacity with limited growth headroom, so expansion focus is on specialty chemicals.
  • Export challenges from Europe due to slowdown are being offset by growing markets in Latin America, China, and the U.S.

2 more points from DMCC Speciality Chemicals Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what DMCC Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • No major CAPEX planned currently; most major investments, including Dahej expansion, are complete.
  • Planned maintenance CAPEX is around INR 1.5 to 2 crores annually, mainly for sulfuric acid plants.
  • Minor incremental investments or debottlenecking might be done, but nothing substantial.
  • A planned CAPEX of about INR 10 to 15 crores is intended, focused on multipurpose plant utilization and possibly setting up dedicated plants for mature products.
  • Future significant CAPEX will require board and shareholder approval.

2 more points from DMCC Speciality Chemicals Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what DMCC Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for DMCC Specialty Chemicals Limited. However, relevant insights from the discussion include: - The company is focused on increasing specialty chemicals sales with room to double current sales, indicating ongoing demand. - New product launches are in progress with commercial sales underway but not yet fully mature. - The company is actively developing new markets, including Latin America and China, to offset European market slowdown. - There is a planned plant shutdown expected to impact production temporarily but no indication of order backlog.

2 more points from DMCC Speciality Chemicals Ltd's call on order book

Pro opens every point from 15K+ earnings calls

DMCC Speciality Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹178 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Atul (Q4 FY25)

    Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…

  • Vidhi Specialty Food Ingredients Ltd (Q4 FY25)

    109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…

  • Chemcon Speciality Chemicals Ltd (Q4 FY25)

    54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Valiant Organics (Q4 FY25)

    Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

DMCC Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were DMCC Speciality Chemicals Ltd Q4 FY25 results?

The chemical industry generally grows faster than India's GDP, indicating potential for above-GDP growth in sales and volumes. The company does not provide specific future earnings or profit projections, preferring not to make forward-looking statements.

What is DMCC Speciality Chemicals Ltd share price analysis?

DMCC Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 26.0 with a market cap of ₹710 Cr. Investors should review the full earnings analysis for detailed insights.

Is DMCC Speciality Chemicals Ltd planning capital expenditure?

No major CAPEX planned currently; most major investments, including Dahej expansion, are complete.

Keep DMCC Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.